BRIEF-Baxalta and Merrimack initiate Phase 1 study of MM-151
May 19, 2016 at 07:22 AM EDT
* Merrimack and Baxalta announce initiation of Phase 1 study of MM-151 in combination with onivyderegimen in metastatic colorectal cancer Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
